One-Year Follow-Up of Conduction Abnormalities After Transcatheter Aortic Valve Implantation With the SAPIEN 3 Valve

ABSTRACT Long-term evolution of new onset conduction abnormalities and need of permanent pacemaker implantation (PPI) after transcatheter aortic valve implantation (TAVI) have not been extensively evaluated. We describe the incidence and time-course of new conduction abnormalities and the rate of PPI with the new generation transcatheter aortic valve prosthesis Edwards SAPIEN 3 (S3). In total, 266 patients with severe aortic stenosis (AS) who underwent TAVI were retrospectively analysed. Twelve-lead electrocardiograms at baseline, after TAVI, at discharge, at 1-, 6- and 12-month follow-up were evaluated to identify conduction abnormalities and PPI requirements to investigate the correlates of PPI. After TAVI, a significant increase in PR interval duration and in QRS complex width was observed. New-onset left bundle branch block (LBBB) was observed in 65 patients (24%) after TAVI. The number of patients with LBBB was maximum at hospital discharge and decreased at 12 month follow-up (39% and 32%, respectively). Thirty-five patients (13%) required PPI during the follow-up. However, paced rhythm was only observed in 7% of the patients with a complete 12 month follow-up. Patients who underwent PPI had a higher prevalence of first degree atrioventricular block, complete right bundle branch block (RBBB) and wider QRS complex at baseline. Baseline RBBB and QRS width immediately after TAVI were the only variables independently associated with PPI. In conclusion, conduction disorders have a temporary nature after TAVI and showed a trend towards stabilization during the following months. With this new generation device, the incidence of new conduction abnormalities requiring PPI is relatively low.